Tech Company Financing Transactions

Neurelis Funding Round

Cormorant Asset Management, Decheng Capital and HBM Healthcare Investments invested in a $114 million Series D funding round for Neurelis. The round was announced by the company on 3/12/2021.

Transaction Overview

Company Name
Announced On
3/12/2021
Transaction Type
Venture Equity
Amount
$114,000,000
Round
Series D
Proceeds Purpose
The company intends to use the funds to commercialize its lead orphan drug product, VALTOCO (diazepam nasal spray), and to continue the development and expansion of its neuroscience pipeline.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3430 Carmel Mountain Rd. 300
San Diego, CA 92121
USA
Email Address
Overview
Neurelis, Inc. is a specialty pharmaceutical company organized to license, develop, and commercialize product candidates for the treatment of central nervous system disorders with a focus on the treatment of acute breakthrough seizures (epilepsy) and acute anxiety episodes.
Profile
Neurelis LinkedIn Company Profile
Social Media
Neurelis Company Twitter Account
Company News
Neurelis News
Facebook
Neurelis on Facebook
YouTube
Neurelis on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Craig Chambliss
  Craig Chambliss LinkedIn Profile  Craig Chambliss Twitter Account  Craig Chambliss News  Craig Chambliss on Facebook
Chief Financial Officer
George Stuart
  George Stuart LinkedIn Profile  George Stuart Twitter Account  George Stuart News  George Stuart on Facebook
Chief Medical Officer
Enrique Carrazana
  Enrique Carrazana LinkedIn Profile  Enrique Carrazana Twitter Account  Enrique Carrazana News  Enrique Carrazana on Facebook
Chief Scientific Officer
Stuart Madden
  Stuart Madden LinkedIn Profile  Stuart Madden Twitter Account  Stuart Madden News  Stuart Madden on Facebook
Vice President
Chuck DeWildt
  Chuck DeWildt LinkedIn Profile  Chuck DeWildt Twitter Account  Chuck DeWildt News  Chuck DeWildt on Facebook
Vice President
Adrian Rabinowicz
  Adrian Rabinowicz LinkedIn Profile  Adrian Rabinowicz Twitter Account  Adrian Rabinowicz News  Adrian Rabinowicz on Facebook
VP - Bus. Development
Thomas Liquard
  Thomas Liquard LinkedIn Profile  Thomas Liquard Twitter Account  Thomas Liquard News  Thomas Liquard on Facebook
VP - General Counsel
Jenny Alonso
  Jenny Alonso LinkedIn Profile  Jenny Alonso Twitter Account  Jenny Alonso News  Jenny Alonso on Facebook
VP - Marketing
Steve Jenner
  Steve Jenner LinkedIn Profile  Steve Jenner Twitter Account  Steve Jenner News  Steve Jenner on Facebook
VP - Regulatory Affairs
Edward Smith
  Edward Smith LinkedIn Profile  Edward Smith Twitter Account  Edward Smith News  Edward Smith on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/12/2021: Pathlock venture capital transaction
Next: 3/12/2021: Icertis venture capital transaction

 

Share this article

 


Where The Data Comes From

We document all VC transactions involving tech companies. VC investment data records on this site come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary